Sökning: onr:"swepub:oai:lup.lub.lu.se:a1cc05ff-15f9-4b8f-994c-dfc635c43836" >
Prostate Cancer Mor...
Prostate Cancer Mortality Reduction by Prostate-Specific Antigen-Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)
-
Roobol, Monique J. (författare)
-
Kerkhof, Melissa (författare)
-
Schroeder, Fritz H. (författare)
-
visa fler...
-
Cuzick, Jack (författare)
-
Sasieni, Peter (författare)
-
Hakama, Matti (författare)
-
Stenman, Ulf Hakan (författare)
-
Ciatto, Stefano (författare)
-
Nelen, Vera (författare)
-
Kwiatkowski, Maciej (författare)
-
Lujan, Marcos (författare)
-
- Lilja, Hans (författare)
- Lund University,Lunds universitet,Klinisk kemi, Malmö,Forskargrupper vid Lunds universitet,Clinical Chemistry, Malmö,Lund University Research Groups
-
Zappa, Marco (författare)
-
Denis, Louis (författare)
-
Recker, Franz (författare)
-
Berenguer, Antonio (författare)
-
Ruutu, Mirja (författare)
-
Kujala, Paula (författare)
-
Bangma, Chris H. (författare)
-
- Aus, Gunnar (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper,Institute of Clinical Sciences
-
Tammela, Teuvo L. J. (författare)
-
Villers, Arnauld (författare)
-
Rebillard, Xavier (författare)
-
Moss, Sue M. (författare)
-
de Koning, Harry J. (författare)
-
- Hugosson, Jonas, 1955 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper,Institute of Clinical Sciences
-
Auvinen, Anssi (författare)
-
visa färre...
-
(creator_code:org_t)
- Elsevier BV, 2009
- 2009
- Engelska.
-
Ingår i: European Urology. - : Elsevier BV. - 1873-7560 .- 0302-2838. ; 56:4, s. 584-591
- Relaterad länk:
-
http://dx.doi.org/10...
-
visa fler...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
https://gup.ub.gu.se...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background: Prostate-specific antigen (PSA) based screening for prostate cancer (PCa) has been shown to reduce prostate specific mortality by 20% in an intention to screen (ITS) analysis in a randomised trial (European Randomised Study of Screening for Prostate Cancer [ERSPC]). This effect may be diluted by nonattendance in men randomised to the screening arm and contamination in men randomised to the control arm. Objective: To assess the magnitude of the PCa-specific mortality reduction after adjustment for nonattendance and contamination. Design, setting, and participants: We analysed the occurrence of PCa deaths during an average follow-up of 9 yr in 162 243 men 55-69 yr of age randomised in seven participating centres of the ERSPC. Centres were also grouped according to the type of randomisation (ie, before or after informed written consent). Intervention: Nonattendance was defined as nonattending the initial screening round in ERSPC. The estimate of contamination was based on PSA use in controls in ERSPC Rotterdam. Measurements: Relative risks (RRs) with 95% confidence intervals (Cis) were compared between an ITS analysis and analyses adjusting for nonattendance and contamination using a statistical method developed for this purpose. Results and limitations: In the ITS analysis, the RR of PCa death in men allocated to the intervention arm relative to the control arm was 0.80 (95% CI, 0.68-0.96). Adjustment for nonattendance resulted in a RR of 0.73 (95% CI, 0.58-0.93), and additional adjustment for contamination using two different estimates led to estimated reductions of 0.69 (95% CI, 0.51-0.92) to 0.71 (95% CI, 0.55-0.93), respectively. Contamination data were obtained through extrapolation of single-centre data. No heterogeneity was found between the groups of centres. Conclusions: PSA screening reduces the risk of dying of PCa by up to 31% in men actually screened. This benefit should be weighed against a degree of over diagnosis and overtreatment inherent in PCa screening. (C) 2009 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Urologi och njurmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Urology and Nephrology (hsv//eng)
Nyckelord
- Non compliance
- Mortality reduction
- Prostate cancer
- Screening
- Contamination
- Adjusted analysis
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Roobol, Monique ...
-
Kerkhof, Melissa
-
Schroeder, Fritz ...
-
Cuzick, Jack
-
Sasieni, Peter
-
Hakama, Matti
-
visa fler...
-
Stenman, Ulf Hak ...
-
Ciatto, Stefano
-
Nelen, Vera
-
Kwiatkowski, Mac ...
-
Lujan, Marcos
-
Lilja, Hans
-
Zappa, Marco
-
Denis, Louis
-
Recker, Franz
-
Berenguer, Anton ...
-
Ruutu, Mirja
-
Kujala, Paula
-
Bangma, Chris H.
-
Aus, Gunnar
-
Tammela, Teuvo L ...
-
Villers, Arnauld
-
Rebillard, Xavie ...
-
Moss, Sue M.
-
de Koning, Harry ...
-
Hugosson, Jonas, ...
-
Auvinen, Anssi
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Urologi och njur ...
- Artiklar i publikationen
-
European Urology
- Av lärosätet
-
Lunds universitet
-
Göteborgs universitet